BrainStorm Cell Therapeutics Inc (BCLI)

[early_retirement2]

NEWS - 3Q finances and corporate update Oct. 17th.

http://ir.brainstorm-cell.com/phoenix.zhtml?c=142287&p=RssLanding&cat=news&id=2304441



Brainstorm to Announce Third Quarter Financial Results And Provide Corporate Updates on Tuesday, October 17


Conference Call and Live Webcast at 8:30am Eastern Time


HACKENSACK, N.J. and PETACH TIKVAH, Israel, Oct. 3, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will announce financial results for the three and nine months ended September 30, 2017, and provide important corporate updates, on Tuesday, October 17.

Logo - hi-res

Tuesday, October 17, 2017 @ 8:30am Eastern Time




Toll Free:

888-395-3237


Israel Investors:

1 80 924 5905


International:

719-325-2349


Conference ID:

4131959


Webcast:

http://public.viavid.com/index.php?id=126580


Replays, available through October 31, 2017




Toll Free:

844-512-2921


International:

412-317-6671


Conference ID:

4131959


About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn® technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. NurOwn has been administered to approximately 75 patients with ALS in clinical trials conducted in the United States and Israel. In a randomized, double-blind, placebo-controlled clinical trial conducted in the U. S., a clinically meaningful benefit was demonstrated by higher response to NurOwn compared with placebo. For more information, visit the company's website at www.brainstorm-cell.com.

CONTACTS

Media:
Uri Yablonka
Chief Business Officer
Brainstorm Cell Therapeutics Inc.
Phone: [phone]
[e-mail]

Investors:
Michael Rice
LifeSci Advisors, LLC
Phone: [phone]
[e-mail]



View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-to-announce-third-quarter-financial-results-and-provide-corporate-updates-on-tuesday-october-17-300530261.html

SOURCE BrainStorm Cell Therapeutics Inc.